廣譽遠(600771.SH):控股子公司獲得《藥品生產許可證》暨通過藥品GMP符合性檢查
格隆匯 12 月 14日丨廣譽遠(600771.SH)公佈,近日,公司控股子公司安康廣譽遠藥業有限公司通過了陝西省藥品監督管理局藥品生產許可證合併GMP符合性現場檢查,並於2020年12月14日收到陝西省藥品監督管理局頒發的《藥品生產許可證》。
企業名稱:安康廣譽遠藥業有限公司;地址:陝西省安康市旬陽縣呂河鎮敖院社區184-1號;生產地址和生產範圍:安康市旬陽縣呂河鎮敖院社區184-1號:中藥飲片【淨制、切制、炒制、炙制(蜜炙、鹽炙、酒炙、醋炙、油炙、薑汁炙)、蒸制、煮制、燉制、燀炙、煅炙、燙制、煨制、制炭、粉碎(含直接口服飲片);含毒性飲片(淨制、切制、蒸制、煮制、燙制、醋炙)】;有效期至:2025年12月7日;證書編號:陝20200009;分類碼:Ay。
此次《藥品生產許可證》的獲得,進一步豐富了公司產品種類,能夠更好的滿足市場需求,提升公司整體的市場競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.